Showing results (941-950 of 3,790) with videos related to

Sort By:
Pageof 379
Oncoimmunology|March 17, 2022
Vasculogenic mimicry structures in melanoma support the recruitment of monocytesLih Y Tan, Michaelia P Cockshell, Eli Moore, et al.
Oncoimmunology|April 28, 2022
CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor developmentEtienne S Melese, Elizabeth Franks, Rachel A Cederberg, et al.
Oncoimmunology|April 28, 2022
A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patientsJulie Le Naour, Zsofia Sztupinszki, Vincent Carbonnier, et al.
Oncoimmunology|January 24, 2022
Beneficial autoimmunity and maladaptive inflammation shape epidemiological links between cancer and immune-inflammatory diseasesJonathan Pol, Juliette Paillet, Céleste Plantureux, et al.
Oncoimmunology|October 1, 2021
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinomaShih-Hung Yang, Li-Chun Lu, Hsiang-Fong Kao, et al.
Oncoimmunology|October 1, 2021
Downregulating testosterone levels enhance immunotherapy efficiencyLuoyang Wang, Guoqiang Jiang, Nan Jing, et al.
Oncoimmunology|April 4, 2022
Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodesLouise Rethacker, Maxime Boy, Valeria Bisio, et al.
Oncoimmunology|February 7, 2022
Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicityYuan-Na Lin, Marcel O Schmidt, Ghada M Sharif, et al.
Oncoimmunology|February 7, 2022
Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposureTassilo L A Wachsmann, Anne K Wouters, Dennis F G Remst, et al.
Pageof 379